Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.08.2024 - 31.07.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- 123 Acurae Pharma GmbH, Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH, BG ALIUD / STADAPHARM GbR, Devatis GmbH, HEXAL AG, TAD Pharma GmbH, Teva GmbH, Viatris Healthcare GmbH, Zentiva Pharma GmbH
- Contract value
- no value published
- Bids received
- 11
- Published
- 19 Jan 2026
- Awarded
- 1 Aug 2024
- Contract start
- 1 Aug 2024
- Contract end
- 14 Aug 2025estimated
- Region
- Hamburg